1. Inhibition of aldose reductase ameliorates ethanol-induced steatosis in HepG2 cells
   Longxin Qiu et al, 2017, Molecular Medicine Reports CrossRef
2. İn Vitro Hepatik Oksidatif Hasarda Karvakrolün Etkinliğinin Araştırılması
   Meryem Nur ATABAY DİNGİL et al, 2022, Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi CrossRef
3. Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease
   Min Wang et al, 2020, Hepatology CrossRef
4. Natural Compounds with Aldose Reductase (AR) Inhibition: A Class of Medicative Agents for Fatty Liver Disease
   Tong Wang et al, 2023, Combinatorial Chemistry & High Throughput Screening CrossRef
5. Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease
   Longxin Qiu et al, 2020, Current Drug Targets CrossRef
6. AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma
   NP Syamprasad et al, 2024, JHEP Reports CrossRef
7. Inhibition of aldose reductase ameliorates alcoholic liver disease by activating AMPK and modulating oxidative stress and inflammatory cytokines
   Changxuan Shi et al, 2017, Molecular Medicine Reports CrossRef
8. Dietary chicory root and chicory inulin trigger changes in energetic metabolism, stress prevention and cytoskeletal proteins in the liver of growing pigs – a proteomic study
   A. Lepczyński et al, 2017, Journal of Animal Physiology and Animal Nutrition CrossRef